| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/2004 | EP1424895A2 Method for expression of small antiviral rna molecules within a cell |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1424892A2 Modulation of angiogenesis by a-beta peptides |
| 06/09/2004 | EP1326631B1 Botulinumtoxin for treating endocrine disorders |
| 06/09/2004 | EP1272148A4 Compositions for metabolic protection and repair of lips |
| 06/09/2004 | EP1267917A4 Angiogenic onchocerca volvulus proteins and uses thereof |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP1036094A4 Cyp7 promoter-binding factors |
| 06/09/2004 | EP1036089B1 Wound healing compositions |
| 06/09/2004 | EP1021134A4 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | EP0956294B1 Thrombin inhibitors |
| 06/09/2004 | EP0934081B1 Antineoplastic conjugates of albumin |
| 06/09/2004 | EP0914415B1 Method and compositions for obtaining mature dendritic cells |
| 06/09/2004 | EP0835101B1 Method of producing sustained-release preparation |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0748225B1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
| 06/09/2004 | EP0547164B1 Methods for the diagnosis and treatment of diabetes |
| 06/09/2004 | DE10254214A1 Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz Oligoribonucleotides for the treatment of degenerative skin changes by RNA interference |
| 06/09/2004 | CN1503816A Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503677A Use of LP 82 to treat hematopoietic disorders |
| 06/09/2004 | CN1503664A Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502994A Detection and treatment of cancer |
| 06/09/2004 | CN1502698A Methods for the recombinant production of antifusogenic peptides |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502695A Mouse cholesterol ester synthetase-2 gene promotor |
| 06/09/2004 | CN1502693A Zymoplasmoid of venom of Deinagkistrodon acutus with hemostatic activity |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502632A Novel TNFR-FC fusion protein |
| 06/09/2004 | CN1502631A Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502626A Novel human protein with cancer-inhibiting function and coding sequence thereof |
| 06/09/2004 | CN1502625A Oligopeptide suppressor of matrix metalloprotease 2 |
| 06/09/2004 | CN1502369A Bioadhesive pharmaceutical compositions based on non-steroidal anti-inflammatory drugs |
| 06/09/2004 | CN1502366A Aerhua melanophore-stimulating hormone cream for treating vitiligo |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152957C Human 6-phosphoglucosamine isomerase, its code sequence and application |
| 06/09/2004 | CN1152714C Ear drops for repairing ear membrane |
| 06/09/2004 | CN1152713C Dried blood factor composition comprising trehalose |
| 06/09/2004 | CN1152712C Freeze-dried composition of bone morphogenetic protein human MP52 |
| 06/09/2004 | CN1152711C Immunoactivato and use of glutathion |
| 06/08/2004 | US6748072 Personal communication center performance display and status alert system |
| 06/08/2004 | US6747784 Compliant mechanism and method of forming same |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6747133 Antibodies against the tumor suppressor gene ING1 |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747131 Phosphorylated fusion proteins |
| 06/08/2004 | US6747129 Target of RNAIII activating protein(TRAP) |
| 06/08/2004 | US6747127 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 06/08/2004 | US6747126 Peptide inhibitors of HIV entry |
| 06/08/2004 | US6747125 Gonadotropic release hormone (gnrh ) antagonists prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads; used to treat steroid-dependent tumors; agonists can be used for control of reproduction |
| 06/08/2004 | US6747063 Augmenting actions of camp in an effector system while reducing camp action in a nociceptive system comprising application of one or more forms of nitrogen oxide or carbon monoxide to a site wherein camp exists |
| 06/08/2004 | US6747060 Non-natural galanin receptor ligands |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/08/2004 | US6747020 Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor |
| 06/08/2004 | US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area |
| 06/08/2004 | US6747009 Peptidomimetic glutathione analogs |
| 06/08/2004 | US6747008 Methods for treating and preventing alopecia |
| 06/08/2004 | US6747007 Cationic, polyphemusin-like peptides |
| 06/08/2004 | US6747006 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6747003 Modified vitamin K-dependent polypeptides |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746866 Preparation of factor XIIIa by gene manipulation |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746861 Human kinase protein and polynucleotides encoding the same |
| 06/08/2004 | US6746859 A recombinant, biologically active, enterokinase light chain, free of enterokinase heavy chain |
| 06/08/2004 | US6746858 Murd protein and gene of Streptococcus pyogenes |
| 06/08/2004 | US6746853 Proteins with insulin-like activity useful in the treatment of diabetes |
| 06/08/2004 | US6746846 Comprise tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions ;may comprise an antigen presenting cell |
| 06/08/2004 | US6746837 Multiple drug resistance gene atrD of aspergillus nidulans |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | US6746670 Regulatory T cells; methods |
| 06/08/2004 | US6746668 Apo-2 ligand |
| 06/08/2004 | US6745763 Vaporizing device for administering sterile medication |
| 06/08/2004 | CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/08/2004 | CA2134535C Method for sterilizing recombinant human serum albumin pharmaceutical preparation |
| 06/08/2004 | CA2100256C A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/05/2004 | CA2410153A1 A novel bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof |
| 06/03/2004 | WO2004046376A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | WO2004046354A1 Oligoribonucleotides for treating degenerative skin disorders by rna interference |
| 06/03/2004 | WO2004046349A2 Human methionine aminopeptidase type 3 |
| 06/03/2004 | WO2004046345A2 Use of hmgb fragments as anti-inflammatory agents |
| 06/03/2004 | WO2004046341A2 Modulation of kiaa0415 expression |